https://www.selleckchem.com/pr....oducts/coelenterazin
e is an important measure which provides additional insight when comparing EBRT to other treatment modalities for PCa. Experiences of African/Afro-Caribbean men on active surveillance (AS) for prostate cancer (PCa) in the United Kingdom (UK) are not well documented. We compared follow-up appointments, adherence, and clinical outcomes among African/Afro-Caribbean men on AS at a high-volume UK hospital with other ethnicities. Men with confirmed low-intermediate risk Pca who attended the AS clinic (2005-2016) and had undergone ≥1 fo